DALLAS, TX - In a landmark decision reached in federal court on Thursday, the U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) have conceded to withdraw social media posts and an online article cautioning against the off-label use of ivermectin in treating COVID-19. This agreement comes after legal action ini…
Substack is the home for great culture

